World of DTC Marketing

JULY 6, 2022

Endpoint News reported “Three major drug distributors are off the hook for what may have been a $2.5 billion payment after a federal judge found them not liable for the opioid epidemic in parts of West Virginia, one of the hardest-hit areas of the country. This is beyond outrageous it’s a classic example of abuse of power. Despite distributing more than 51.3 million doses of oxycodone and hydrocodone to pharmacies in Cabell County and the city of Huntington over less than a decade, M

Pharma 238

Pharma Distribution Prescription Doctors 238

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Elsewhere, San Diego, California-based Heron Therapeutics announced restructuring and layoffs for 34% of its workforce.

Marketing 129

Marketing Biopharma Pharma Retail 129

MedCity News

JULY 6, 2022

Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

Pharma 128

Pharma Consulting Patients Manufacturing 128

Pharmaceutical Technology

JULY 6, 2022

The European Commission (EC) has granted approval for the expanded conditional marketing authorization (CMA) of Novavax’s Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), in the European Union (EU) for adolescents of the age 12 to 17 years. A protein-based vaccine, NVX-CoV2373 is made from the genetic sequence of the SARS-CoV-2 virus’ first strain. The latest development comes after the Committee for Medicinal Products for Human Use of the European Medicines Agency granted a positive recommendation in

Safety 105

Safety Medicine Pharmaceutical Marketing 105

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

JULY 6, 2022

The low-income patient populations who bear disproportionate disease burdens are the same populations who are most likely to face barriers in health technology use, according to Courtney Lyles co-founder of S.O.L.V.E. Health Tech, UCSF’s health equity accelerator. The program she co-founded seeks to address this problem by conducting research with digital health startups about how their products can better serve low-income patients.

Patients 120

Patients 120

Pharmaceutical Technology

JULY 6, 2022

Europe was the fastest growing region for data analytics hiring among pharmaceutical industry companies in the three months ending May. The number of roles in Europe made up 11.8% of total data analytics jobs - up from 11.1% in the same quarter last year. That was followed by North America, which saw a -0.4 year-on-year percentage point change in data analytics roles.

Pharmaceutical 98

Pharmaceutical Leads Marketing 98

pharmaphorum

JULY 6, 2022

The FDA approves new cancer treatments in half the time of the EMA – but does faster mean better? And how can regulators balance timely access with robust safety? Cancer patients in Europe wait an average of almost eight months longer for access to breakthrough medications than their American counterparts. A new cross-sectional study has found that the FDA green lit 95% of the 89 new oncology therapies approved between 2010 and 2019 before the EMA, with the Europeans trailing the Americans by a

Safety 92

Safety FDA Medicine Patients 92

MedCity News

JULY 6, 2022

Sarepta Therapeutics has more clinical data showing the safety and efficacy of its experimental gene therapy for Duchenne muscular dystrophy. A pivotal Phase 3 test is already underway and could post data next year but the company is also talking with regulators about the possibility of a submission under the accelerated approval pathway.

Safety 117

Safety FDA Biopharma Pharma 117

pharmaphorum

JULY 6, 2022

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will “vigorously” defend itself. CureVac revealed yesterday that had filed suit in the Düsseldorf Regional Court, claiming that mRNA technology used in BioNTech’s Comirnaty vaccine – partnered with Pfizer – infringes its intellectual property.

Biopharma 90

Biopharma Engineering Sales Pharmaceutical 90

MedCity News

JULY 6, 2022

OSF Ventures — the investment arm of Peoria, Illinois-based OSF HealthCare — gained a new leader last week when Mayank Taneja took the helm. In the role, Taneja oversees $250 million in assets across three funds. The venture capital arm is currently focused on investing in solutions to take care outside the four walls of a hospital and increase workforce retention, he said.

Healthcare 113

Healthcare Healthcare 113

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

JULY 6, 2022

The FDA has granted a priority review to Roche’s T-cell engager Lunsumio as a treatment for follicular lymphoma (FL), setting up a decision on the drug by 29 December. The first-in-class drug – which targets CD20 and CD3 – is being assessed by the regulator for relapsed or refractory FL, the most common slow-growing form of non-Hodgkin lymphoma (NHL), after two or more prior systemic therapies.

FDA 83

FDA Competition Patients Manufacturing 83

MedCity News

JULY 6, 2022

A new set of 5 CMS codes introduced for 2022, RTM allows physical therapists and other qualified healthcare professionals to bill for monitoring and managing a patient’s MSK care plan remotely.

Healthcare 113

Healthcare Healthcare Management 113

PharmaVoice

JULY 6, 2022

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off.

Pharmaceutical 98

Pharmaceutical 98

Pharmaceutical Technology

JULY 6, 2022

CureVac has filed a patent infringement lawsuit against BioNTech in Germany over intellectual property rights of messenger ribonucleic acid (mRNA) technology. The mRNA technology was used for the development of the Covid-19 vaccine. The lawsuit was filed against BioNTech and two of its subsidiaries in the German Regional Court in Düsseldorf. CureVac sought fair compensation for infringement of a portfolio of its intellectual property rights used to produce and sell BioNTech and Pfizer’s mRNA Cov

Distribution 72

Distribution Engineering Pharmaceutical Sales 72

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaVoice

JULY 6, 2022

Ratings agency Moody’s lays out the risk exposure for industry leaders.

Pharma 104

Pharma 104

Pharmaceutical Technology

JULY 6, 2022

Scientists at the National Institutes of Health (NIH) unit National Institute of Neurological Disorders and Stroke (NINDS) have found that Covid-19-induced immune response could damage the blood vessels of the brain and may lead to short and long-term neurological symptoms. . NINDS team analysed changes in the brain of nine individuals who died following Covid-19 infection.

Leads 64

Leads Patients Pharmaceutical 64

pharmaphorum

JULY 6, 2022

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections. The JV has been formed German pharma companies Boehringer Ingelheim and Evotec with in vitro diagnostics specialist bioMérieux, with the objective of developing new antimicrobial drugs backed by diagnostics to quickly identify pathogens and their resistance patterns and guide treatment.

Pharma 59

Pharma Patients Medicine Management 59

Pharmaceutical Technology

JULY 6, 2022

The proportion of pharmaceutical companies hiring for big data related positions rose in June 2022 compared with the equivalent month last year, with 68.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 65.7% of companies who were hiring for big data related jobs a year ago and the same as the figure of 68.4% in May 2022.

Pharmaceutical 64

Pharmaceutical Recruitment 64

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

pharmaphorum

JULY 6, 2022

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of lives in the state. District court judge David Faber rejected a call by prosecutors to force the distributors to pay $2.5 billion to fund an abatement plan to tackle an epidemic of deaths in Huntington and Cabell County – the hardest hit areas of the state – by shipping millions of opioid pills there.

Doctors 59

Doctors Prescription Manufacturing Marketing 59

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Elsewhere, San Diego, California-based Heron Therapeutics announced restructuring and layoffs for 34% of its workforce.

Marketing 64

Marketing Biopharma Pharma Retail 64

PharmaTimes

JULY 6, 2022

Deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies

Manufacturing 87

Manufacturing 87

Toolyt

JULY 6, 2022

Maintaining a long-lasting consistent performance from the sales team can be very complex. Sometimes motivation is all it takes to do something big! And, that’s the reason sales reps always tend to seek some extra motivation to close more deals. To enhance the extra zeal of motivation and the competitive edge, Gamification is the ideal process to win over your sales agents.

Sales 52

Sales CRM Sales process Competition 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

PharmaTimes

JULY 6, 2022

Clinical trial evidence suggests that Tremfya is effective when compared with a placebo

87

87

Legacy MEDSearch

JULY 6, 2022

annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer. With the new appointments, annalise.ai expects to further accelerate its global market presence and entry into the US market following recent FDA approvals for part of its comprehens

Healthcare 52

Healthcare Healthcare FDA Networking 52

Impetus Digital

JULY 6, 2022

Dr. Bassil Akra , CEO of AKRA TEAM GmbH , sat down with me for a deep dive into the new approval process for medical devices in the EU. Among many other things, he shared his insights into how Medical Device and In Vitro Diagnostic companies can get safe, qualitative, and well-performing products onto the EU market with minimal delays. Here is a sneak peek of our conversation: Q: I’m curious if these new regulations relating to medical devices are also correlated with the private and pub

Patients 52

Patients Marketing Professional Services Medical 52

Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic.

Prospecting 52

Prospecting Retail Manufacturing Networking 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Toolyt

JULY 6, 2022

Maintaining a long-lasting consistent performance from the sales team can be very complex. Sometimes motivation is all it takes to do something big! And, that’s the reason sales reps always tend to seek some extra motivation to close more deals. To enhance the extra zeal of motivation and the competitive edge, Gamification is the ideal process to win over your sales agents.

Sales 52

Sales CRM Sales process Competition 52

pharmaphorum

JULY 6, 2022

The FDA has started an accelerated review of Eisai and Biogen’s a new amyloid-targeting antibody lecanemab for Alzheimer’s disease, with a 6 January deadline that keep them ahead of closest rival Eli Lilly. The US regulator has been reviewing lecanemab as a treatment for patients with early-stage Alzheimer’s and amyloid plaques in the brain under a rolling biologics license application which completed in May.

FDA 52

FDA Prospecting Marketing Patients 52

Verb

JULY 6, 2022

By now, you’ve probably heard about MARKET and the unique social shopping and selling experiences it offers to shoppers and sellers. For the past few months, we have been recruiting sellers to the MARKET platform, and sellers have had the opportunity to host a few live events to showcase the live experience. Individual storefronts are presenting their products at live events that are happening on the MARKET platform every couple of days.

Recruitment 52

Recruitment Marketing Sales 52

MedReps

JULY 6, 2022

The time has come. You’ve been working hard, making your numbers, and going above and beyond what’s expected of you. However, you feel like you’re stuck in your current position with no room for advancement. Asking for a promotion at work can be a delicate balance – you don’t want to seem entitled or ungrateful, but you also know that you deserve more responsibility and compensation.

Medical sales reps 49

Medical sales reps Sales Medical sales Medical 49

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients